郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Radiosynthesis and evaluation of an 18F-labeled positron emission tomography (PET) radioligand for metabotropic glutamate receptor subtype 4 (mGlu4).

期刊：Journal of medicinal chemistry发表年份：2014作者：Kun-Eek Kil; Pekka Poutiainen; Zhaoda Zhang; Aijun Zhu; Ji-Kyung Choi; Kimmo Jokivarsi; Anna-Liisa Brownell
阅读更多 →

药效评价Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.

期刊：Journal of medicinal chemistry发表年份：2014作者：Andrew P Riley; Chad E Groer; David Young; Amy W Ewald; Bronwyn M Kivell; Thomas E Prisinzano
阅读更多 →

药效评价The phosphoinositide-dependent protein kinase 1 inhibitor, UCN-01, induces fragmentation: possible role of metalloproteinases.

期刊：European journal of pharmacology发表年份：2014作者：Rocío Alcántara-Hernández; Aurelio Hernández-Méndez; J Adolfo García-Sáinz
阅读更多 →

药效评价Orally active opioid μ/δ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2014作者：Kenjiro Matsumoto; Minoru Narita; Naotaka Muramatsu; Terumi Nakayama; Kaori Misawa; Mariko Kitajima; Kimihito Tashima; Lakshmi A Devi; Tsutomu Suzuki; Hiromitsu Takayama; Syunji Horie
阅读更多 →